申请人:Epizyme, Inc.
公开号:US20190135819A1
公开(公告)日:2019-05-09
Provided herein are compounds of Formula (I):
and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, wherein X, R
1
, R
1a
, R
2a
, R
2b
, R
2c
, R
2d
, are as defined herein, and Ring HET is a 6-membered monocyclic heteroaryl ring system of Formula:
wherein L
2
, R
13
, G
8
, G
10
, G
11
, and G
12
are as defined herein. Compounds of the present invention are useful for inhibiting CARM1 activity. Methods of using the compounds for treating CARM1-mediated disorders are also described.